In cardiomyocytes, the KCNQ1/KCNE1 channel complex mediates the slow delayed-rectifier current (IKs), pivotal during the repolarization phase of the ventricular action potential. Mutations in IKs cause long QT syndrome (LQTS), a syndrome with a prolonged QT interval on the ECG, which increases the risk of ventricular arrhythmia and sudden cardiac death. One potential therapeutical intervention for LQTS is based on targeting IKs channels to restore channel function and/or the physiological QT interval. Polyunsaturated fatty acids (PUFAs) are potent activators of KCNQ1 channels and activate IKs channels by binding to two different sites, one in the voltage sensor domain - which shifts the voltage dependence to more negative voltages - and the other in the pore domain - which increases the maximal conductance of the channels (Gmax). However, the mechanism by which PUFAs increase the Gmax of the IKs channels is still poorly understood. In addition, it is unclear why IKs channels have a very small single-channel conductance and a low open probability or whether PUFAs affect any of these properties of IKs channels. Our results suggest that the selectivity filter in KCNQ1 is normally unstable, contributing to the low open probability, and that the PUFA-induced increase in Gmax is caused by a stabilization of the selectivity filter in an open-conductive state.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527429PMC
http://dx.doi.org/10.7554/eLife.95852DOI Listing

Publication Analysis

Top Keywords

iks channels
24
selectivity filter
12
iks
8
channels
8
increase gmax
8
low open
8
open probability
8
pufa stabilizes
4
stabilizes conductive
4
conductive state
4

Similar Publications

Inhibitory Effects of Cenobamate on Multiple Human Cardiac Ion Channels and Possible Arrhythmogenic Consequences.

Biomolecules

December 2024

Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, 050095 Bucharest, Romania.

Cenobamate is a novel third-generation antiepileptic drug used for the treatment of focal onset seizures and particularly for multi-drug-resistant epilepsy; it acts on multiple targets: GABA receptors (EC 42-194 µM) and persistent neuronal Na currents (IC 59 µM). Side effects include QT interval shortening with >20 ms, but not <300 ms. Our in vitro cardiac safety pharmacology study was performed via whole-cell patch-clamp on HEK293T cells with persistent/inducible expression of human cardiac ion channel isoforms hNav1.

View Article and Find Full Text PDF

Identification of KCNE6, a new member of the KCNE family of potassium channel auxiliary subunits.

Commun Biol

December 2024

Division of Integrative Physiology, Department of Physiology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.

The KCNE family (KCNE1-5) is a group of single transmembrane auxiliary subunits for the voltage-gated K channel KCNQ1. The KCNQ1-KCNE complexes are crucial for numerous physiological processes including ventricular repolarization and K recycling in epithelial cells. We identified a new member of the KCNE family, "KCNE6", from zebrafish.

View Article and Find Full Text PDF

Dual effects of mefenamic acid on the I molecular complex.

Br J Pharmacol

February 2025

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

Article Synopsis
  • - Mefenamic acid, a non-steroidal anti-inflammatory drug, can both enhance and inhibit cardiac ion currents formed by KCNQ1 and KCNE1 channels, revealing its dual effect on these channels, especially in patients with long and short QT syndromes.
  • - The study used whole cell patch clamp techniques and molecular dynamics simulations to investigate how mefenamic acid interacts with these channels, particularly noting its inhibition at high concentrations and its potential to preserve some current potentiation effects.
  • - Findings emphasize the importance of specific structural regions in the KCNQ1/KCNE1 channels that influence how drugs like mefenamic acid affect ion current, which has significant implications for developing treatments for certain genetic long QT syndrome mutations.*
View Article and Find Full Text PDF

In cardiomyocytes, the KCNQ1/KCNE1 channel complex mediates the slow delayed-rectifier current (IKs), pivotal during the repolarization phase of the ventricular action potential. Mutations in IKs cause long QT syndrome (LQTS), a syndrome with a prolonged QT interval on the ECG, which increases the risk of ventricular arrhythmia and sudden cardiac death. One potential therapeutical intervention for LQTS is based on targeting IKs channels to restore channel function and/or the physiological QT interval.

View Article and Find Full Text PDF
Article Synopsis
  • The compound N-arachidonoyl-L-serine (ARA-S) activates the Kv7.1/KCNE1 ion channel, which plays a crucial role in heart function, by shortening action potential duration and QT interval in guinea pig hearts.
  • A study using the two-electrode voltage clamp technique shows that ARA-S affects Kv7.1/KCNE1 channels similarly across guinea pig, rabbit, and human models, indicating broad applicability for research.
  • Findings suggest that both rabbit and guinea pig animal models are appropriate for further investigations of ARA-S's cardiac effects, given their comparable responses to the compound.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!